FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048355520> ?p ?o ?g. }

• W3048355520 endingPage "1412" @default.
• W3048355520 startingPage "1402" @default.
• W3048355520 abstract "Background Co-trimoxazole, a sulfonamide antibiotic, is used to treat a variety of infections worldwide, and it remains a common first-line medicine for prophylaxis against Pneumocystis jiroveci pneumonia. However, it can cause severe cutaneous adverse reaction (SCAR), including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms. The pathomechanism of co-trimoxazole–induced SCAR remains unclear. Objective We aimed to investigate the genetic predisposition of co-trimoxazole–induced SCAR. Methods We conducted a multicountry case-control association study that included 151 patients with of co-trimoxazole–induced SCAR and 4631 population controls from Taiwan, Thailand, and Malaysia, as well as 138 tolerant controls from Taiwan. Whole-genome sequencing was performed for the patients and population controls from Taiwan; it further validated the results from Thailand and Malaysia. Results The whole-genome sequencing study (43 case patients vs 507 controls) discovered that the single-nucleotide polymorphism rs41554616, which is located between the HLA-B and MICA loci, had the strongest association with co-trimoxazole–induced SCAR (P = 8.2 × 10−9; odds ratio [OR] = 7.7). There were weak associations of variants in co-trimoxazole–related metabolizing enzymes (CYP2D6, GSTP1, GCLC, N-acetyltransferase [NAT2], and CYP2C8). A replication study using HLA genotyping revealed that HLA-B∗13:01 was strongly associated with co-trimoxazole–induced SCAR (the combined sample comprised 91 case patients vs 2545 controls [P = 7.2 × 10−21; OR = 8.7]). A strong HLA association was also observed in the case patients from Thailand (P = 3.2 × 10−5; OR = 3.6) and Malaysia (P = .002; OR = 12.8), respectively. A meta-analysis and phenotype stratification study further indicated a strong association between HLA-B∗13:01 and co-trimoxazole–induced drug reaction with eosinophilia and systemic symptoms (P = 4.2 × 10−23; OR = 40.1). Conclusion This study identified HLA-B∗13:01 as an important genetic factor associated with co-trimoxazole–induced SCAR in Asians. Co-trimoxazole, a sulfonamide antibiotic, is used to treat a variety of infections worldwide, and it remains a common first-line medicine for prophylaxis against Pneumocystis jiroveci pneumonia. However, it can cause severe cutaneous adverse reaction (SCAR), including Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reaction with eosinophilia and systemic symptoms. The pathomechanism of co-trimoxazole–induced SCAR remains unclear. We aimed to investigate the genetic predisposition of co-trimoxazole–induced SCAR. We conducted a multicountry case-control association study that included 151 patients with of co-trimoxazole–induced SCAR and 4631 population controls from Taiwan, Thailand, and Malaysia, as well as 138 tolerant controls from Taiwan. Whole-genome sequencing was performed for the patients and population controls from Taiwan; it further validated the results from Thailand and Malaysia. The whole-genome sequencing study (43 case patients vs 507 controls) discovered that the single-nucleotide polymorphism rs41554616, which is located between the HLA-B and MICA loci, had the strongest association with co-trimoxazole–induced SCAR (P = 8.2 × 10−9; odds ratio [OR] = 7.7). There were weak associations of variants in co-trimoxazole–related metabolizing enzymes (CYP2D6, GSTP1, GCLC, N-acetyltransferase [NAT2], and CYP2C8). A replication study using HLA genotyping revealed that HLA-B∗13:01 was strongly associated with co-trimoxazole–induced SCAR (the combined sample comprised 91 case patients vs 2545 controls [P = 7.2 × 10−21; OR = 8.7]). A strong HLA association was also observed in the case patients from Thailand (P = 3.2 × 10−5; OR = 3.6) and Malaysia (P = .002; OR = 12.8), respectively. A meta-analysis and phenotype stratification study further indicated a strong association between HLA-B∗13:01 and co-trimoxazole–induced drug reaction with eosinophilia and systemic symptoms (P = 4.2 × 10−23; OR = 40.1). This study identified HLA-B∗13:01 as an important genetic factor associated with co-trimoxazole–induced SCAR in Asians." @default.
• W3048355520 created "2020-08-13" @default.
• W3048355520 creator A5000201500 @default.
• W3048355520 creator A5000749939 @default.
• W3048355520 creator A5003027597 @default.
• W3048355520 creator A5015696941 @default.
• W3048355520 creator A5017089774 @default.
• W3048355520 creator A5019719023 @default.
• W3048355520 creator A5023457264 @default.
• W3048355520 creator A5032071579 @default.
• W3048355520 creator A5032324121 @default.
• W3048355520 creator A5037100478 @default.
• W3048355520 creator A5037368636 @default.
• W3048355520 creator A5045400237 @default.
• W3048355520 creator A5048561277 @default.
• W3048355520 creator A5049497121 @default.
• W3048355520 creator A5050201483 @default.
• W3048355520 creator A5056356887 @default.
• W3048355520 creator A5058219953 @default.
• W3048355520 creator A5058827722 @default.
• W3048355520 creator A5060923318 @default.
• W3048355520 creator A5068441645 @default.
• W3048355520 creator A5071897528 @default.
• W3048355520 creator A5072358989 @default.
• W3048355520 creator A5074349318 @default.
• W3048355520 creator A5076370197 @default.
• W3048355520 creator A5076408723 @default.
• W3048355520 creator A5078704171 @default.
• W3048355520 creator A5078738149 @default.
• W3048355520 creator A5079921975 @default.
• W3048355520 creator A5080327178 @default.
• W3048355520 creator A5080630699 @default.
• W3048355520 creator A5082527740 @default.
• W3048355520 creator A5089789832 @default.
• W3048355520 date "2021-04-01" @default.
• W3048355520 modified "2023-10-14" @default.
• W3048355520 title "Whole genome sequencing identifies genetic variants associated with co-trimoxazole hypersensitivity in Asians" @default.
• W3048355520 cites W150961072 @default.
• W3048355520 cites W1975591667 @default.
• W3048355520 cites W1999369567 @default.
• W3048355520 cites W2002877000 @default.
• W3048355520 cites W2023689571 @default.
• W3048355520 cites W2025161685 @default.
• W3048355520 cites W2025816743 @default.
• W3048355520 cites W2045391651 @default.
• W3048355520 cites W2049902892 @default.
• W3048355520 cites W2052372045 @default.
• W3048355520 cites W2064076476 @default.
• W3048355520 cites W2065199938 @default.
• W3048355520 cites W2066724445 @default.
• W3048355520 cites W2067978628 @default.
• W3048355520 cites W2083508836 @default.
• W3048355520 cites W2087191895 @default.
• W3048355520 cites W2088162928 @default.
• W3048355520 cites W2088348604 @default.
• W3048355520 cites W2089378839 @default.
• W3048355520 cites W2092786402 @default.
• W3048355520 cites W2093579159 @default.
• W3048355520 cites W2104951811 @default.
• W3048355520 cites W2109696646 @default.
• W3048355520 cites W2112182958 @default.
• W3048355520 cites W2115832251 @default.
• W3048355520 cites W2121948279 @default.
• W3048355520 cites W2122570228 @default.
• W3048355520 cites W2122840946 @default.
• W3048355520 cites W2133494322 @default.
• W3048355520 cites W2134537227 @default.
• W3048355520 cites W2137146513 @default.
• W3048355520 cites W2155803913 @default.
• W3048355520 cites W2159946748 @default.
• W3048355520 cites W2170964221 @default.
• W3048355520 cites W2171286995 @default.
• W3048355520 cites W2199063317 @default.
• W3048355520 cites W2317624504 @default.
• W3048355520 cites W2321102680 @default.
• W3048355520 cites W2342351290 @default.
• W3048355520 cites W2345540828 @default.
• W3048355520 cites W2405053777 @default.
• W3048355520 cites W2416296981 @default.
• W3048355520 cites W2468769822 @default.
• W3048355520 cites W2749256686 @default.
• W3048355520 cites W2775968124 @default.
• W3048355520 cites W2786261596 @default.
• W3048355520 cites W2787407277 @default.
• W3048355520 cites W2790109257 @default.
• W3048355520 cites W2803525987 @default.
• W3048355520 cites W2938955219 @default.
• W3048355520 cites W2939707671 @default.
• W3048355520 cites W2967493198 @default.
• W3048355520 cites W2981628170 @default.
• W3048355520 cites W3001686774 @default.
• W3048355520 doi "https://doi.org/10.1016/j.jaci.2020.08.003" @default.
• W3048355520 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32791162" @default.
• W3048355520 hasPublicationYear "2021" @default.
• W3048355520 type Work @default.
• W3048355520 sameAs 3048355520 @default.
• W3048355520 citedByCount "37" @default.
• W3048355520 countsByYear W30483555202021 @default.

• next